A review of patient reported outcomes labelling for oncology drugs approved by the FDA and the EMA (2012-2016)

31 January 2019 - In recent years, the FDA has granted patient-reported outcome labelling to very few oncology drugs. ...

Read more →

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards

19 October 2016 - Measures of health-related quality of life and other patient-reported outcomes generate important data in cancer randomised trials ...

Read more →

Integrating patients’ views in clinical studies of anti-cancer medicines

22 April 2016 - The EMA has published new guidance on the use of patient-reported outcome (PRO) measures in oncology ...

Read more →